Cover Image
Market Research Report
Product code 
1052534

Global Companion Diagnostic Technologies Market Insights and Forecast to 2028

Published: | QYResearch | 110 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Companion Diagnostic Technologies Market Insights and Forecast to 2028
Published: January 18, 2022
QYResearch
Content info: 110 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.

Market Analysis and Insights: Global Companion Diagnostic Technologies Market

The global Companion Diagnostic Technologies market size is projected to reach US$ 6057.7 million by 2028, from US$ 2771.3 million in 2021, at a CAGR of 11.3% during 2022-2028.

Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic Technologies market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic Technologies market.

Global Companion Diagnostic Technologies Scope and Market Size

Companion Diagnostic Technologies market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Immunohistochemistry
  • Molecular Diagnostics

Segment by Application

  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Auto immune & Inflammation
  • Virology
  • Others

By Company

  • Dako (Agilent Technologies)
  • Qiagen
  • Roche
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • bioMerieux
  • Myriad Genetics
  • Resonance Health Ltd.
  • Leica Microsystems
  • Danaher

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Immunohistochemistry
    • 1.2.3 Molecular Diagnostics
  • 1.3 Market by Application
    • 1.3.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Oncology
    • 1.3.3 Cardiovascular
    • 1.3.4 Central Nervous System
    • 1.3.5 Auto immune & Inflammation
    • 1.3.6 Virology
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Companion Diagnostic Technologies Market Perspective (2017-2028)
  • 2.2 Companion Diagnostic Technologies Growth Trends by Region
    • 2.2.1 Companion Diagnostic Technologies Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Companion Diagnostic Technologies Historic Market Size by Region (2017-2022)
    • 2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Region (2023-2028)
  • 2.3 Companion Diagnostic Technologies Market Dynamics
    • 2.3.1 Companion Diagnostic Technologies Industry Trends
    • 2.3.2 Companion Diagnostic Technologies Market Drivers
    • 2.3.3 Companion Diagnostic Technologies Market Challenges
    • 2.3.4 Companion Diagnostic Technologies Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Companion Diagnostic Technologies Players by Revenue
    • 3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2017-2022)
    • 3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2017-2022)
  • 3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
  • 3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
    • 3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2021
  • 3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
  • 3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
  • 3.7 Date of Enter into Companion Diagnostic Technologies Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Technologies Breakdown Data by Type

  • 4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2017-2022)
  • 4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2023-2028)

5 Companion Diagnostic Technologies Breakdown Data by Application

  • 5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2017-2022)
  • 5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Companion Diagnostic Technologies Market Size (2017-2028)
  • 6.2 North America Companion Diagnostic Technologies Market Size by Type
    • 6.2.1 North America Companion Diagnostic Technologies Market Size by Type (2017-2022)
    • 6.2.2 North America Companion Diagnostic Technologies Market Size by Type (2023-2028)
    • 6.2.3 North America Companion Diagnostic Technologies Market Share by Type (2017-2028)
  • 6.3 North America Companion Diagnostic Technologies Market Size by Application
    • 6.3.1 North America Companion Diagnostic Technologies Market Size by Application (2017-2022)
    • 6.3.2 North America Companion Diagnostic Technologies Market Size by Application (2023-2028)
    • 6.3.3 North America Companion Diagnostic Technologies Market Share by Application (2017-2028)
  • 6.4 North America Companion Diagnostic Technologies Market Size by Country
    • 6.4.1 North America Companion Diagnostic Technologies Market Size by Country (2017-2022)
    • 6.4.2 North America Companion Diagnostic Technologies Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Companion Diagnostic Technologies Market Size (2017-2028)
  • 7.2 Europe Companion Diagnostic Technologies Market Size by Type
    • 7.2.1 Europe Companion Diagnostic Technologies Market Size by Type (2017-2022)
    • 7.2.2 Europe Companion Diagnostic Technologies Market Size by Type (2023-2028)
    • 7.2.3 Europe Companion Diagnostic Technologies Market Share by Type (2017-2028)
  • 7.3 Europe Companion Diagnostic Technologies Market Size by Application
    • 7.3.1 Europe Companion Diagnostic Technologies Market Size by Application (2017-2022)
    • 7.3.2 Europe Companion Diagnostic Technologies Market Size by Application (2023-2028)
    • 7.3.3 Europe Companion Diagnostic Technologies Market Share by Application (2017-2028)
  • 7.4 Europe Companion Diagnostic Technologies Market Size by Country
    • 7.4.1 Europe Companion Diagnostic Technologies Market Size by Country (2017-2022)
    • 7.4.2 Europe Companion Diagnostic Technologies Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2017-2028)
  • 8.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type
    • 8.2.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Companion Diagnostic Technologies Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Application
    • 8.3.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Companion Diagnostic Technologies Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region
    • 8.4.1 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Companion Diagnostic Technologies Market Size (2017-2028)
  • 9.2 Latin America Companion Diagnostic Technologies Market Size by Type
    • 9.2.1 Latin America Companion Diagnostic Technologies Market Size by Type (2017-2022)
    • 9.2.2 Latin America Companion Diagnostic Technologies Market Size by Type (2023-2028)
    • 9.2.3 Latin America Companion Diagnostic Technologies Market Share by Type (2017-2028)
  • 9.3 Latin America Companion Diagnostic Technologies Market Size by Application
    • 9.3.1 Latin America Companion Diagnostic Technologies Market Size by Application (2017-2022)
    • 9.3.2 Latin America Companion Diagnostic Technologies Market Size by Application (2023-2028)
    • 9.3.3 Latin America Companion Diagnostic Technologies Market Share by Application (2017-2028)
  • 9.4 Latin America Companion Diagnostic Technologies Market Size by Country
    • 9.4.1 Latin America Companion Diagnostic Technologies Market Size by Country (2017-2022)
    • 9.4.2 Latin America Companion Diagnostic Technologies Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2017-2028)
  • 10.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type
    • 10.2.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Companion Diagnostic Technologies Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Application
    • 10.3.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Companion Diagnostic Technologies Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country
    • 10.4.1 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Dako (Agilent Technologies)
    • 11.1.1 Dako (Agilent Technologies) Company Details
    • 11.1.2 Dako (Agilent Technologies) Business Overview
    • 11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
    • 11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.1.5 Dako (Agilent Technologies) Recent Developments
  • 11.2 Qiagen
    • 11.2.1 Qiagen Company Details
    • 11.2.2 Qiagen Business Overview
    • 11.2.3 Qiagen Companion Diagnostic Technologies Introduction
    • 11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.2.5 Qiagen Recent Developments
  • 11.3 Roche
    • 11.3.1 Roche Company Details
    • 11.3.2 Roche Business Overview
    • 11.3.3 Roche Companion Diagnostic Technologies Introduction
    • 11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.3.5 Roche Recent Developments
  • 11.4 Abbott Laboratories
    • 11.4.1 Abbott Laboratories Company Details
    • 11.4.2 Abbott Laboratories Business Overview
    • 11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
    • 11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.4.5 Abbott Laboratories Recent Developments
  • 11.5 Thermo Fisher Scientific
    • 11.5.1 Thermo Fisher Scientific Company Details
    • 11.5.2 Thermo Fisher Scientific Business Overview
    • 11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
    • 11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.5.5 Thermo Fisher Scientific Recent Developments
  • 11.6 bioMerieux
    • 11.6.1 bioMerieux Company Details
    • 11.6.2 bioMerieux Business Overview
    • 11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
    • 11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.6.5 bioMerieux Recent Developments
  • 11.7 Myriad Genetics
    • 11.7.1 Myriad Genetics Company Details
    • 11.7.2 Myriad Genetics Business Overview
    • 11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
    • 11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.7.5 Myriad Genetics Recent Developments
  • 11.8 Resonance Health Ltd.
    • 11.8.1 Resonance Health Ltd. Company Details
    • 11.8.2 Resonance Health Ltd. Business Overview
    • 11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
    • 11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.8.5 Resonance Health Ltd. Recent Developments
  • 11.9 Leica Microsystems
    • 11.9.1 Leica Microsystems Company Details
    • 11.9.2 Leica Microsystems Business Overview
    • 11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
    • 11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.9.5 Leica Microsystems Recent Developments
  • 11.10 Danaher
    • 11.10.1 Danaher Company Details
    • 11.10.2 Danaher Business Overview
    • 11.10.3 Danaher Companion Diagnostic Technologies Introduction
    • 11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2017-2022)
    • 11.10.5 Danaher Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Companion Diagnostic Technologies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Immunohistochemistry
  • Table 3. Key Players of Molecular Diagnostics
  • Table 4. Global Companion Diagnostic Technologies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Companion Diagnostic Technologies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Companion Diagnostic Technologies Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Companion Diagnostic Technologies Market Share by Region (2017-2022)
  • Table 8. Global Companion Diagnostic Technologies Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Companion Diagnostic Technologies Market Share by Region (2023-2028)
  • Table 10. Companion Diagnostic Technologies Market Trends
  • Table 11. Companion Diagnostic Technologies Market Drivers
  • Table 12. Companion Diagnostic Technologies Market Challenges
  • Table 13. Companion Diagnostic Technologies Market Restraints
  • Table 14. Global Companion Diagnostic Technologies Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Companion Diagnostic Technologies Revenue Share by Players (2017-2022)
  • Table 16. Global Top Companion Diagnostic Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2021)
  • Table 17. Ranking of Global Top Companion Diagnostic Technologies Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Technologies Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Companion Diagnostic Technologies Product Solution and Service
  • Table 21. Date of Enter into Companion Diagnostic Technologies Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Companion Diagnostic Technologies Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Companion Diagnostic Technologies Revenue Market Share by Type (2017-2022)
  • Table 25. Global Companion Diagnostic Technologies Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Companion Diagnostic Technologies Revenue Market Share by Type (2023-2028)
  • Table 27. Global Companion Diagnostic Technologies Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Companion Diagnostic Technologies Revenue Share by Application (2017-2022)
  • Table 29. Global Companion Diagnostic Technologies Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Companion Diagnostic Technologies Revenue Share by Application (2023-2028)
  • Table 31. North America Companion Diagnostic Technologies Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Companion Diagnostic Technologies Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Companion Diagnostic Technologies Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Companion Diagnostic Technologies Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Companion Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Companion Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Companion Diagnostic Technologies Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Companion Diagnostic Technologies Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Companion Diagnostic Technologies Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Companion Diagnostic Technologies Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Companion Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Companion Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Companion Diagnostic Technologies Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Companion Diagnostic Technologies Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Companion Diagnostic Technologies Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Companion Diagnostic Technologies Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Companion Diagnostic Technologies Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Companion Diagnostic Technologies Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Companion Diagnostic Technologies Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Companion Diagnostic Technologies Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Companion Diagnostic Technologies Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Companion Diagnostic Technologies Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Companion Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Companion Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Companion Diagnostic Technologies Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Companion Diagnostic Technologies Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Companion Diagnostic Technologies Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Companion Diagnostic Technologies Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Companion Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Companion Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Dako (Agilent Technologies) Company Details
  • Table 62. Dako (Agilent Technologies) Business Overview
  • Table 63. Dako (Agilent Technologies) Companion Diagnostic Technologies Product
  • Table 64. Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 65. Dako (Agilent Technologies) Recent Developments
  • Table 66. Qiagen Company Details
  • Table 67. Qiagen Business Overview
  • Table 68. Qiagen Companion Diagnostic Technologies Product
  • Table 69. Qiagen Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 70. Qiagen Recent Developments
  • Table 71. Roche Company Details
  • Table 72. Roche Business Overview
  • Table 73. Roche Companion Diagnostic Technologies Product
  • Table 74. Roche Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 75. Roche Recent Developments
  • Table 76. Abbott Laboratories Company Details
  • Table 77. Abbott Laboratories Business Overview
  • Table 78. Abbott Laboratories Companion Diagnostic Technologies Product
  • Table 79. Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 80. Abbott Laboratories Recent Developments
  • Table 81. Thermo Fisher Scientific Company Details
  • Table 82. Thermo Fisher Scientific Business Overview
  • Table 83. Thermo Fisher Scientific Companion Diagnostic Technologies Product
  • Table 84. Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 85. Thermo Fisher Scientific Recent Developments
  • Table 86. bioMerieux Company Details
  • Table 87. bioMerieux Business Overview
  • Table 88. bioMerieux Companion Diagnostic Technologies Product
  • Table 89. bioMerieux Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 90. bioMerieux Recent Developments
  • Table 91. Myriad Genetics Company Details
  • Table 92. Myriad Genetics Business Overview
  • Table 93. Myriad Genetics Companion Diagnostic Technologies Product
  • Table 94. Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 95. Myriad Genetics Recent Developments
  • Table 96. Resonance Health Ltd. Company Details
  • Table 97. Resonance Health Ltd. Business Overview
  • Table 98. Resonance Health Ltd. Companion Diagnostic Technologies Product
  • Table 99. Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 100. Resonance Health Ltd. Recent Developments
  • Table 101. Leica Microsystems Company Details
  • Table 102. Leica Microsystems Business Overview
  • Table 103. Leica Microsystems Companion Diagnostic Technologies Product
  • Table 104. Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 105. Leica Microsystems Recent Developments
  • Table 106. Danaher Company Details
  • Table 107. Danaher Business Overview
  • Table 108. Danaher Companion Diagnostic Technologies Product
  • Table 109. Danaher Revenue in Companion Diagnostic Technologies Business (2017-2022) & (US$ Million)
  • Table 110. Danaher Recent Developments
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Companion Diagnostic Technologies Market Share by Type: 2021 VS 2028
  • Figure 2. Immunohistochemistry Features
  • Figure 3. Molecular Diagnostics Features
  • Figure 4. Global Companion Diagnostic Technologies Market Share by Application: 2021 VS 2028
  • Figure 5. Oncology Case Studies
  • Figure 6. Cardiovascular Case Studies
  • Figure 7. Central Nervous System Case Studies
  • Figure 8. Auto immune & Inflammation Case Studies
  • Figure 9. Virology Case Studies
  • Figure 10. Others Case Studies
  • Figure 11. Companion Diagnostic Technologies Report Years Considered
  • Figure 12. Global Companion Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global Companion Diagnostic Technologies Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Companion Diagnostic Technologies Market Share by Region: 2021 VS 2028
  • Figure 15. Global Companion Diagnostic Technologies Market Share by Players in 2021
  • Figure 16. Global Top Companion Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by Companion Diagnostic Technologies Revenue in 2021
  • Figure 18. North America Companion Diagnostic Technologies Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America Companion Diagnostic Technologies Market Size Market Share by Type (2017-2028)
  • Figure 20. North America Companion Diagnostic Technologies Market Size Market Share by Application (2017-2028)
  • Figure 21. North America Companion Diagnostic Technologies Market Size Share by Country (2017-2028)
  • Figure 22. United States Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Companion Diagnostic Technologies Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Companion Diagnostic Technologies Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe Companion Diagnostic Technologies Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe Companion Diagnostic Technologies Market Size Share by Country (2017-2028)
  • Figure 28. Germany Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Companion Diagnostic Technologies Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific Companion Diagnostic Technologies Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific Companion Diagnostic Technologies Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific Companion Diagnostic Technologies Market Size Share by Region (2017-2028)
  • Figure 38. China Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Latin America Companion Diagnostic Technologies Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America Companion Diagnostic Technologies Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America Companion Diagnostic Technologies Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America Companion Diagnostic Technologies Market Size Share by Country (2017-2028)
  • Figure 48. Mexico Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Companion Diagnostic Technologies Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa Companion Diagnostic Technologies Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa Companion Diagnostic Technologies Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa Companion Diagnostic Technologies Market Size Share by Country (2017-2028)
  • Figure 54. Turkey Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE Companion Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. Dako (Agilent Technologies) Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 58. Qiagen Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 59. Roche Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 60. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 62. bioMerieux Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 63. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 64. Resonance Health Ltd. Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 65. Leica Microsystems Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 66. Danaher Revenue Growth Rate in Companion Diagnostic Technologies Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed